Related Experiment Video
Updated: Jul 2, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop
Shivi Chauhan1, Shivani Jaiswal1, Vibhuti Jakhmola1
1Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noda, 201313, India.
Abstract:
The crucial role played by the oncogenic expression of TP53, stemming from mutation or amyloid formation, in various human malignancies has been extensively studied over the past two decades. Interestingly, the potential role of TP53 as a crucial player in modulating immune responses has provided new insight into the field of cancer biology. The loss of p53's transcriptional functions and/or the acquisition of tumorigenic properties can efficiently modulate the recruitment and functions of myeloid and lymphoid cells, ultimately leading to the evasion of immune responses in human tumors. Consequently, the oncogenic nature of the tumor suppressor p53 can dynamically alter the function of immune cells, providing support for tumor progression and metastasis. This review comprehensively explores the dual role of p53 as both the guardian of the genome and an oncogenic driver, especially in the context of regulation of autophagy, apoptosis, the tumor microenvironment, immune cells, innate immunity, and adaptive immune responses. Additionally, the focus of this review centers on how p53 status in the immune response can be harnessed for the development of tailored therapeutic strategies and their potential application in immunotherapy against human malignancies.
Insights
The tumor suppressor p53, often mutated in cancer, can paradoxically drive tumor growth by suppressing immune responses. Understanding this dual role is key for developing new immunotherapies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- TP53 mutations are common in human cancers, influencing tumor progression.
- Emerging evidence highlights TP53's role in modulating the immune system within the tumor microenvironment.
Approach:
- This review synthesizes current research on TP53's multifaceted functions in cancer immunity.
- It examines how TP53 impacts autophagy, apoptosis, and immune cell dynamics.
Key Points:
- Mutated TP53 can promote oncogenesis by impairing anti-tumor immune responses.
- TP53 influences both innate and adaptive immunity, affecting immune cell recruitment and function.
- The dual role of p53 as a tumor suppressor and oncogenic driver is explored.
Conclusions:
- Harnessing TP53's influence on immune responses offers potential for novel cancer immunotherapy strategies.
- Targeting p53 status may lead to more effective treatments for human malignancies.
Related Concept Videos
Abnormal Proliferation
Tumor Immunotherapy
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

